Life Sciences

Merck updates grand jury investigation, announces denial of class action status for Vioxx suit

Pharma Compliance Alert, March 25, 2009

A grand jury is investigating Merck’s research, marketing, and selling activities for its withdrawn painkiller Vioxx, the company announced.

Merck had previously disclosed the government’s investigation, which began in 2004, but received a letter from the U.S. Attorney's Office for the District of Massachusetts advising it of the probe March 23.

Read more about Merck's announcements about Vioxx.

Most Popular

Related Articles